These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3006861)

  • 1. Cholinergic approaches to the treatment of Alzheimer's disease.
    Hollander E; Mohs RC; Davis KL
    Br Med Bull; 1986 Jan; 42(1):97-100. PubMed ID: 3006861
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical trials with the cholinergic drug RS 86 in Alzheimer's disease (AD) and senile dementia of the Alzheimer type (SDAT).
    Wettstein A; Spiegel R
    Psychopharmacology (Berl); 1984; 84(4):572-3. PubMed ID: 6441959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of cholinergic drug effects on memory in Alzheimer's disease.
    Brinkman SD; Gershon S
    Neurobiol Aging; 1983; 4(2):139-45. PubMed ID: 6355883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can the pattern of neuropsychological improvement obtained with cholinergic drugs be used to infer a cholinergic mechanism in other nootropic drugs?
    Gainotti G; Nocentini U; Sena E
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13 Suppl():S47-59. PubMed ID: 2694229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No response to high-dose muscarinic agonist therapy in Alzheimer's disease.
    Mouradian MM; Mohr E; Williams JA; Chase TN
    Neurology; 1988 Apr; 38(4):606-8. PubMed ID: 3281057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physostigmine and arecoline: effects of intravenous infusions in Alzheimer presenile dementia.
    Christie JE; Shering A; Ferguson J; Glen AI
    Br J Psychiatry; 1981 Jan; 138():46-50. PubMed ID: 7023592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cholinergic treatment strategies in Alzheimer's disease].
    Kurz A; Rüster P; Romero B; Zimmer R
    Nervenarzt; 1986 Oct; 57(10):558-69. PubMed ID: 3785472
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of 4-aminopyridine in elderly patients with Alzheimer's disease.
    Wesseling H; Agoston S; Van Dam GB; Pasma J; DeWit DJ; Havinga H
    N Engl J Med; 1984 Apr; 310(15):988-9. PubMed ID: 6366565
    [No Abstract]   [Full Text] [Related]  

  • 9. Muscarinic agonist therapy of Alzheimer's disease. A clinical trial of RS-86.
    Bruno G; Mohr E; Gillespie M; Fedio P; Chase TN
    Arch Neurol; 1986 Jul; 43(7):659-61. PubMed ID: 3524514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal models of Alzheimer's disease: behavior, pharmacology, transplants.
    Haroutunian V; Kanof PD; Tsuboyama GK; Campbell GA; Davis KL
    Can J Neurol Sci; 1986 Nov; 13(4 Suppl):385-93. PubMed ID: 2878711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Alzheimer's disease: hopes and reality.
    Gauthier S; Gauthier L; Bouchard R; Quirion R; Sultan S
    Can J Neurol Sci; 1991 Aug; 18(3 Suppl):439-41. PubMed ID: 1933695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of dementia.
    Klawans HL; Genovese N
    Neurol Clin; 1986 May; 4(2):459-67. PubMed ID: 2872586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RS 86 in the treatment of Alzheimer's disease: cognitive and biological effects.
    Hollander E; Davidson M; Mohs RC; Horvath TB; Davis BM; Zemishlany Z; Davis KL
    Biol Psychiatry; 1987 Sep; 22(9):1067-78. PubMed ID: 3651528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alzheimer's disease. Biological and pharmacotherapeutic aspects].
    Hinzen DH
    Fortschr Med; 1986 Jun; 104(23-24):469-71. PubMed ID: 3017825
    [No Abstract]   [Full Text] [Related]  

  • 15. 4-Aminopyridine derivatives with antiamnesic activity.
    Andreani A; Leoni A; Locatelli A; Morigi R; Rambaldi M; Pietra C; Villetti G
    Eur J Med Chem; 2000 Jan; 35(1):77-82. PubMed ID: 10733605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cholinergic agents in Huntington's disease: a reappraisal.
    Nutt JG
    Neurology; 1983 Jul; 33(7):932-5. PubMed ID: 6223236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic progress--review XVIII Alzheimer's disease.
    Kendall MJ; Chellingsworth MC; Main AN
    J Clin Hosp Pharm; 1985 Dec; 10(4):327-36. PubMed ID: 2869054
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacological correction of Alzheimer's disease (review of the literature)].
    Groppa SA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(9):110-6. PubMed ID: 1686127
    [No Abstract]   [Full Text] [Related]  

  • 19. Potential role of muscarinic agonists in Alzheimer's disease.
    Avery EE; Baker LD; Asthana S
    Drugs Aging; 1997 Dec; 11(6):450-9. PubMed ID: 9413702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cholinergic agents in the treatment of Alzheimer's disease].
    Zemishlany Z; Davidson M; Davis KL
    Harefuah; 1987 Dec; 113(12):401-4. PubMed ID: 3330722
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.